Wellspect HealthCare Introduces Surity™ Female External Catheter for Women with Urinary Incontinence
Wellspect HealthCare, an esteemed leader in continence care solutions, has recently announced the launch of its innovative product, the Surity™ Female External Catheter, in the U.S. market. This groundbreaking device aims to provide effective management for women suffering from severe urinary incontinence, a condition that affects over 13 million women in the United States alone. The ramifications of severe urinary incontinence extend well beyond mere physical discomfort; they impact everyday life routines, leading to sleep disruption, emotional distress, and caregiver exhaustion. The Surity™ catheter addresses this critical need by offering a non-invasive, user-friendly solution that safeguards the dignity and comfort of its users.
The Surity™ Female External Catheter is designed with the needs of women in mind. It integrates seamlessly into daily routines as it works in conjunction with compatible urine collection systems. Wellspect HealthCare has been pioneering in continence care for more than 40 years, and the introduction of Surity™ marks its entry into a new category of urinary management. This launch underscores the company's commitment to offering practical and compassionate solutions that empower individuals facing challenging health conditions.
Chris Schlenk, Group Vice President of Wellspect HealthCare, emphasizes the transformative impact of the Surity™ catheter: "Severe urinary incontinence affects millions of women, many of whom juggle multiple health issues. Our goal is to restore comfort, confidence, and peace of mind for those coping with incontinence. The Surity™ catheter is designed to prevent leakage, protect skin integrity, and allow for extended use overnight, ultimately helping our users manage incontinence complications with greater ease."
Using the device promotes a more predictable management routine, which is essential for older adults, individuals with neurological conditions, and those with mobility challenges. The introduction of Surity™ is timely and necessary, as caregivers and healthcare providers have long sought effective tools to administer dignified and reliable care. By alleviating the fears and concerns associated with urinary incontinence, Wellspect HealthCare aims to give women and their caregivers back their quality of life and the ability to engage fully in daily activities.
As patients look for reliable care options, the Surity™ Female External Catheter stands out as a game changer. It balances effectiveness with user-friendliness, ensuring that both patients and caregivers can feel confident in managing urinary incontinence with dignity. The device is available for home purchase at www.surity.care and will soon expand its availability to healthcare institutions, furthering Wellspect's outreach and support to those in need.
Looking ahead, Wellspect HealthCare anticipates introducing more products in this innovative lineup, including the Surity™ Urinary Management System and a male external catheter later this year. Such advancements reflect Wellspect's ongoing dedication to enhancing the quality of life for individuals managing continence care needs. For more information on Surity™ and to explore its offerings, visit www.surity.care.
Wellspect HealthCare operates as a subsidiary of Dentsply Sirona, committed to enriching the lives of those affected by bladder and bowel dysfunction. With a workforce of roughly 1,200 employees and operations in over 40 countries, Wellspect strives to improve user experiences across the continuum of care in health services. Renowned for its innovative LoFric® catheters, Wellspect has proven itself a pioneer in the industry since its founding in 1983, continuing its legacy of advancing comfortable and effective health solutions. The company ensures that all products stand up to high quality standards while minimizing environmental impact, a principle central to its operations.
The Surity™ Female External Catheter is designed with the needs of women in mind. It integrates seamlessly into daily routines as it works in conjunction with compatible urine collection systems. Wellspect HealthCare has been pioneering in continence care for more than 40 years, and the introduction of Surity™ marks its entry into a new category of urinary management. This launch underscores the company's commitment to offering practical and compassionate solutions that empower individuals facing challenging health conditions.
Chris Schlenk, Group Vice President of Wellspect HealthCare, emphasizes the transformative impact of the Surity™ catheter: "Severe urinary incontinence affects millions of women, many of whom juggle multiple health issues. Our goal is to restore comfort, confidence, and peace of mind for those coping with incontinence. The Surity™ catheter is designed to prevent leakage, protect skin integrity, and allow for extended use overnight, ultimately helping our users manage incontinence complications with greater ease."
Using the device promotes a more predictable management routine, which is essential for older adults, individuals with neurological conditions, and those with mobility challenges. The introduction of Surity™ is timely and necessary, as caregivers and healthcare providers have long sought effective tools to administer dignified and reliable care. By alleviating the fears and concerns associated with urinary incontinence, Wellspect HealthCare aims to give women and their caregivers back their quality of life and the ability to engage fully in daily activities.
As patients look for reliable care options, the Surity™ Female External Catheter stands out as a game changer. It balances effectiveness with user-friendliness, ensuring that both patients and caregivers can feel confident in managing urinary incontinence with dignity. The device is available for home purchase at www.surity.care and will soon expand its availability to healthcare institutions, furthering Wellspect's outreach and support to those in need.
Looking ahead, Wellspect HealthCare anticipates introducing more products in this innovative lineup, including the Surity™ Urinary Management System and a male external catheter later this year. Such advancements reflect Wellspect's ongoing dedication to enhancing the quality of life for individuals managing continence care needs. For more information on Surity™ and to explore its offerings, visit www.surity.care.
About Wellspect HealthCare
Wellspect HealthCare operates as a subsidiary of Dentsply Sirona, committed to enriching the lives of those affected by bladder and bowel dysfunction. With a workforce of roughly 1,200 employees and operations in over 40 countries, Wellspect strives to improve user experiences across the continuum of care in health services. Renowned for its innovative LoFric® catheters, Wellspect has proven itself a pioneer in the industry since its founding in 1983, continuing its legacy of advancing comfortable and effective health solutions. The company ensures that all products stand up to high quality standards while minimizing environmental impact, a principle central to its operations.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.